Sysmex America Expands Use of PTC’s ThingWorx IIoT Platform
NEEDHAM, MA, USA, Feb 7, 2018 - PTC (NASDAQ: PTC) and Sysmex America announced that Sysmex has expanded its use of the ThingWorx Industrial Innovation Platform to enable Sysmex to revolutionize the delivery of blood test results with the Sysmex XW-100 automated hematology CBC analyzer.
Primary doctors can provide blood test results in minutes, on-site, with the new Sysmex XW-100
The XW-100 is the first automated hematology analyzer developed for CLIA-waived use. Instead of sending blood samples to outside laboratories and awaiting the results, the XW-100 makes it possible for one of the most frequently requested blood tests, the CBC, to be performed in medical offices where patients are first treated. On-site blood test results are available to patients in as few as three minutes.
The pursuit of IoT innovation led Sysmex to adopt ThingWorx. The Industrial Innovation Platform enabled Sysmex to greatly expand the availability of product data and implement transformative connected solutions that were previously beyond reach. Prior to the XW-100, virtually all hematology analyzers required skilled clinical personnel to perform blood sample analysis and validate results. This ground-breaking innovation enables blood tests to be safely performed by a broader range of practitioners, improving access to and speed of care.
“The Sysmex Innovation team continues to deliver exceptional value by leveraging the ThingWorx Industrial Innovation Platform,” said Ralph Taylor, chief executive officer, Sysmex America. “The combination of the ThingWorx Industrial Innovation Platform with the XW-100 enables Sysmex to revolutionize the delivery of common blood test results by reducing time to diagnosis, enabling faster treatment plans, and improving the efficiency of health care delivery.”
“Sysmex has embraced continual innovation as an integral part of its core business model,” said Jim Heppelmann, president and CEO, PTC. “Leveraging ThingWorx enables Sysmex America to continue to deliver high-value IoT-enabled solutions to its customers and help retain its leadership position in an intensely competitive market. We congratulate Sysmex on this breakthrough technology.”
The announcement of a customer’s selection or expansion of PTC software is not necessarily indicative of the timing of recognition of related revenue or the amount of revenue for any particular period or that any related applicable implementation and deployment activities are complete.
About Sysmex America
Sysmex America, Inc. distributes and supports a diverse portfolio of best-in-class, in vitro diagnostic hematology and clinical laboratory products in the U.S., Canada and Latin America. It is the U.S. regional office of Sysmex Corporation, a trusted world leader in clinical laboratory solutions that optimize efficiency, operations and financial performance in the lab, located in Kobe, Japan. Sysmex is reshaping the health care of tomorrow at the clinical laboratory level by transcending the boundaries of diagnostic science and serving as the pulse of reliable, accountable care. In 2017, Forbes magazinenamed Sysmex the most innovative company in the health care equipment and services category. For more information about Sysmex America, visit www.sysmex.com/us.
About PTC (NASDAQ: PTC)
PTC helps companies around the world reinvent the way they design, manufacture, operate, and service things in and for a smart, connected world. In 1986 we revolutionized digital 3D design, and in 1998 were first to market with Internet-based product lifecycle management. Today, our leading industrial innovation platform and field-proven solutions enable you to unlock value at the convergence of the physical and digital worlds. With PTC, manufacturers and an ecosystem of partners and developers can capitalize on the promise of the Internet of Things and augmented reality technology today and drive the future of innovation. For more information, visit www.ptc.com.